Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Mendor Announces CE Marking for its Diabetes Management Platform

June 18, 2013

ESPOO, Finland, June 18, 2013 /PRNewswire/ –

Finnish diabetes technology company Mendor announces today the CE mark for its
groundbreaking diabetes management platform, Mendor Balance(R). This cloud-based platform
seeks to introduce significant benefits to all the key stakeholders: patients, health care
professionals, payers and the pharma industry.

Mendor Balance enables people living with diabetes to effortlessly share their blood
glucose monitoring results with their caregiver from most glucose meters in the market
today. Balance provides professionals with a set of tools to efficiently manage a clinic
full of patients, with a future pipeline of real-life decision support protocols.

CE Mark Considered an Important Milestone for Treatment Individualization

The IVD (in vitro diagnostic) products have a clearly defined regulatory environment
which is currently not common practice in software development designed to support
diabetes management. Mendor’s passionate team has been working extremely hard and built a
product that meets all the regulatory specifications, now realized in the form of CE
marking of Mendor Balance.

“I am very proud of our skillful software and clinical team for enabling the CE mark
for Mendor Balance platform. This is the first CE marked meter agnostic platform in EU for
storing and sharing blood glucose data. CE mark for Mendor Balance is an important step
towards scalable and automated blood glucose analysis and decision support system, which
are necessary features for blood glucose profiling and treatment individualization”,
states Antti Virkamaki, Endocrinologist and the Medical Director of Mendor.

Built to Scale Up and Adapt to Real-Life Diabetes Management

Diabetes is a major global health challenge. Mendor Balance is designed to give a new
tool set for tackling escalating costs and ever scarcer resources. Mendor is currently
running a number of patient trials, where the tools for blood glucose profiling are
validated and the platform is fine-tuned for real-life clinical practice.

“I am very happy that we have come this far with Mendor Balance. Balance is an
integral part of the future vision of Mendor in revolutionizing diabetes treatment with
better glucose monitoring and data analysis. Big thanks and hats off to the awesome team
who makes all this possible!”, said Mendor’s CEO and co-founder, Kristian Ranta

        Media Contact:
        Sanna Usva -Mgmt Assistant
        Tel: +358-9-315-77-300
        E-mail: info@mendor.com

Images available on request. For more information, visit: http://www.mendor.com

SOURCE Mendor


Source: PR Newswire